Commercialization License. Medytox hereby grants AEON and its Affiliates a non-exclusive, royalty bearing, irrevocable (except pursuant to Sections 9.2 or 9.3 or the occurrence of the circumstances described in Section 13.6) right and license to the Licensed Rights to Commercialize and obtain or maintain the Marketing Authorization and all Regulatory Materials related to any Licensed Product in the Territory (the “Commercialization License”).
Appears in 4 contracts
Samples: Settlement and License Agreement (AEON Biopharma, Inc.), Settlement and License Agreement (AEON Biopharma, Inc.), Settlement and License Agreement (AEON Biopharma, Inc.)
